Advanced unresectable Urothelial Cancer – GSK – IQVIA EPON
People with Urothelial Cancer are asked to participate in a research study being conducted by Icahn School of Medicine at Mount Sinai.
You may be eligible to participate in this study if you:
- Are a male or female at least 18 years of age
- Have Histologically confirmed locally advanced or metastatic or locally advanced/unresectable urothelial carcinoma
- Able to provide, a tumor tissue sample
You may NOT participate in this study if you:
- Have active brain and/or leptomeningeal disease
- Have history of malignancy other than urothelial cancer within the last 3 years
- Have cirrhosis or current unstable liver or biliary disease
- Have an active infection
- Have a history of bleeding diathesis
- Have known immunodeficiency virus (HIV) infection, hepatitis B, or hepatitis C
- Are pregnant or breastfeeding
Contact Information
Philip Garcia, Clinical Research Coordinator
1 Gustave Levy Place Box 1128
New York, NY 10029
Phone: (212) 824-7312
Email: pHILIP.GARCIA@MSSM.EDU